LEO Pharma reveal positive results from delgocitinib research
Phase 3 clinical trial focuses on adults with moderate-to-severe chronic hand eczema
Read More
Tag: delgocitnib
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
